3034

Quall Holdings Co., Ltd.

クオールホールディングス株式会社
Healthcare · Pharmaceutical Retailers
Qol Holdings Co., Ltd., together with its subsidiaries, engages in the pharmacy, BPO, and pharmaceutical businesses in Japan. The company operates dispensing pharmacies through one-on-one store opening based on one-on-one trust relationships with medical institutions. It also provides contract MR staffing; clinical research and development support services in the areas of food and pharmaceuticals; education and training services; and dispatch clinical research associates to support clinical trials. In addition, the company produce sales promotion materials for pharmaceuticals, as well as pamphlets and websites for medical institutions. Further, it engages in pharmaceutical manufacturing business; medical professional referral and dispatch business for the business areas, including pharmacist, medical clerical work, dispensing work, occupational physician, health nurse, nurse, and registered sales clerk; and business succession, health, and productivity management consulting business. The company was formerly known as Qol Co., Ltd. and changed its name to Qol Holdings Co., Ltd. in October 2018. The company was founded in 1992 and is headquartered in Tokyo, Japan.
← Companies
Price
¥1,843
Market Cap
¥69.5B
Ent. Value
¥83.8B
Net Debt
−¥14.3B
Shares Out.
37.7M
P / E
13.4×
EV / EBIT
6.2×
P / Book
1.21×
P / NCAV
N/M
Div. Yield
1.84%
Financials
Metric FY 2024
EDINET ↗
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
Net Sales ¥264.0B ¥180.1B ¥170.0B ¥166.2B
Cost of Sales ¥224.9B ¥156.8B ¥146.5B ¥143.0B
Gross Profit ¥39.1B ¥23.2B ¥23.5B ¥23.2B
SG&A ¥25.6B ¥14.9B ¥14.0B ¥13.3B
Operating Income ¥13.5B ¥8.3B ¥9.5B ¥9.9B
Non-Operating Income ¥784M ¥1.2B ¥836M ¥413M
Non-Operating Expenses ¥418M ¥245M ¥233M ¥173M
Interest Expense ¥223M ¥109M ¥89M ¥101M
Ordinary Income ¥13.8B ¥9.3B ¥10.1B ¥10.1B
Pre-tax Income ¥12.8B ¥8.9B ¥9.6B ¥9.7B
Income Taxes ¥5.4B ¥4.0B ¥3.9B ¥4.2B
Current Tax ¥4.6B ¥4.0B ¥3.9B ¥4.3B
Deferred Tax ¥798M ¥6M ¥3M ¥-142M
Net Income (owners) ¥5.2B ¥4.9B ¥5.7B ¥5.5B
Minority Interest ¥2.3B ¥0M ¥1M ¥5M
Comprehensive Income ¥7.5B ¥4.9B ¥5.7B ¥5.6B
EBITDA ¥21.8B ¥13.6B ¥14.4B ¥14.6B
Goodwill Amort. (J-GAAP) ¥4.3B ¥3.4B ¥3.2B ¥3.2B
EPS ¥137.97 ¥131.11 ¥152.96 ¥149.51
Shares Outstanding 37.7M 37.7M 37.7M 37.7M
Shares Issued (total) 38.9M 38.9M 38.9M 38.9M
Treasury Shares 1.2M 1.2M 1.2M 1.2M